×

What are you searching for?




Banking/Finance

4 Min read

Freeline

Published On 26 Dec 2019 09:27 AM


SHARE THIS ARTICLE  


The UK quality treatment biotech Freeline Therapeutics is to get speculation worth €72M (£61.1M) from the UK VC firm Syncona in a Series C round to finance the clinical improvement of quality treatments for the blood issue hemophilia B, Fabry illness, and other uncommon conditions. Of the €72M duty, Syncona has just wired €36M to Freeline.  Freeline will get the remainder of the cash at an undisclosed later date. The ....


Tags : freeline, united kingdom, quality, treatment, encoding,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)